Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured

Immediately prior to and 8 weeks after the start of treatment, sigma-1 receptor concentration and mental status, including depressive symptoms (Hamilton Depression Rating Scale; HAM-D), were measured. For the measurement of plasma sigma-1 receptor concentration, blood plasma samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Western blots were performed using a specific antibody that acts against the sigma-1 receptor, and the net densities of each band were quantified. == Results == All participants showed improvement in depressive symptoms, which was indicated by a significant decrease in the HAM-D scores. The mean plasma sigma-1 receptor concentration also increased significantly following antidepressant treatment. However, no significant correlations were found between changes in plasma sigma-1 receptor concentration and changes in HAM-D scores. == Conclusion == In this preliminary study, we demonstrated that the sigma-1 receptor concentration in plasma increases following antidepressant treatment in patients with late-life MDD. Further studies are warranted to confirm this finding with a larger number of patients. Keywords:sigma-1 receptor, late-life depression, depressive symptoms, antidepressant treatment == Introduction == Among various biological markers proposed for mood disorders, the recently identified sigma-1 receptor is promising, as it is known to play a significant role in neural transmission of mood by regulating N-methyl-D-aspartate (NMDA) receptors, thereby modulating glutamate activity.1The sigma-1 receptor was originally proposed by Martin et al2in the 1970s as an opioid receptor subtype. Subsequent pharmacological studies have demonstrated that the sigma-1 receptor is unique and distinct among opioid receptors.3,12The sigma-1 receptor, which has a molecular weight of 25 kDa, is a protein consisting of 223 amino acids with two transmembrane regions, and it is mainly found in the endoplasmic membrane. In addition to its receptor functions, the sigma-1 receptor has recently been shown to function as a chaperone to stabilize the three-dimensional structure of inositol trisphosphate 3 receptors within the endoplasmic membrane, therefore facilitating intracellular adenosine triphosphate production.313The sigma-1 receptor exists in a wide range of human being tissues from your central nervous system to the peripheral organs, including the brain, liver, sexual glands, kidney, immune organs, and retina.14 In the brain, the sigma-1 receptor is specifically distributed in Cyantraniliprole D3 the hippocampus and amygdala, and it takes on a particularly important part in neural Rabbit Polyclonal to C14orf49 formation, the induction of differentiation, and in spinal cord formation.14,15In addition, the sigma-1 receptor offers significant affinity for a wide range of pharmacological agents including antidepressants, antipsychotics, antidementia drugs, antiepileptics, and additional psychotrophic drugs.10,16,17The physiological functions of the sigma-1 receptor in the cellular level includes regulation of: 1) Ca2+channels in NMDA receptors and endoplasmic membranes; 2) K+channels; 3) free neurotransmitters including dopamine; 4) cellular differentiation; 5) rules of Cyantraniliprole D3 intracellular lipid distribution; 6) behavioral sensitization to cocaine and amphetamines; and 7) cognitive functions.14Studies in the molecular level are ongoing to further elucidate the physiological functions of sigma-1 receptors. Concerning the pathogenesis of major depression, recent neuroimaging studies have shown atrophy of the hippo-campus and prefrontal cortices in individuals with major depression, and postmortem studies Cyantraniliprole D3 have shown neuronal cell loss in the hippocampus in stressed out individuals, as well as a decrease in the number of glial cells in the prefrontal cortices, implicating these areas as pathognomonic substrates of major depression.1820In addition, it has been suggested that antidepressant effects are brought about by neurogenesis or nerve growth factors, including brain-derived neurotrophic factor and insulin-like growth factor-1, and neurogenesis has been proposed like a cellular-level magic size for recovery from depression.21 Decreased sigma-1 receptor activity appears to play a crucial part in the pathophysiology of depression at the level of neurogenesis. In animal studies, sigma-1 receptor knockout mice showed increased immobility inside a pressured swimming test like a depressive like phenotype, and an agonist of the sigma-1 receptor showed antidepressant effects in animal models, including within the pressured swimming test and during a tail-hanging test.2226 Although insight into the relationship between sigma-1 receptors and major depression has been gained from.